Danaher Corporation (DHR)
NYSE·Healthcare·Medical - Diagnostics & Research
$200.31
-0.15%
Mkt Cap $144.11B
Analyst Ratings
Buy
14
Hold
4
Sell
0
Price Target (52 analysts)
$230.89
Range $200.00 – $265.00
Implied Upside
+15.3%
Consensus $230.89 vs current $200.31